Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome

Sacher, Frédéric; Probst, Vincent; Iesaka, Yoshito; Jacon, Peggy; Laborderie, Julien; Mizon-Gérard, Frédérique; Mabo, Philippe; Reuter, Sylvain; Lamaison, D; Takahashi, Yoshihide; O’Neill, Mark; Garrigue, Stéphane; Pierre, Bertrand; Jaı̈s, Pierre; Pasquié, Jean‐Luc; Hocini, Mélèze; Salvador-Mazenq, M; Nogami, Akihiko; Amiel, A; Defaye, Pascal; Bordachar, Pierre; Bovéda, Serge; Maury, Philippe; Klug, Didier; Babuty, Dominique; Haı̈ssaguerre, Michel; Mansourati, Jacques; Clémenty, Jacques; Le Marec, Hervé

doi:10.1161/circulationaha.106.628537

Public

Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome

Published in Circulation • Nov 21, 2006

Authors:

Frédéric Sacher

Vincent Probst

Yoshito Iesaka

Abstract

BACKGROUND: Brugada syndrome is an arrhythmogenic disease characterized by an increased risk of sudden cardiac death (SCD) by ventricular fibrillation. At present, an implantable cardioverter-defibrillator (ICD) is the recommended therapy in high-risk patients. This multicenter study reports the out...

Subject

Medicine

Brugada syndrome

Ventricular fibrillation

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!